ADMA Biologics, Inc. (ADMA) vs BioCryst Pharmaceuticals, Inc. (BCRX)
A side-by-side comparison of ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADMA
ADMA Biologics, Inc.
$10.18HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
BCRX
BioCryst Pharmaceuticals, Inc.
$8.02HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — ADMA vs BCRX
growth of $100 · dividends reinvested · last 10yADMA +50.9% (+4.2%/yr)BCRX +78.8% (+6.0%/yr)BCRX compounded faster over this window
ADMA BCRX
ADMA vs BCRX: by the numbers
- •ADMA is the larger company ($2.36B vs $2.04B market cap).
- •ADMA is profitable (32.98% net margin) while BCRX runs a net loss (-40.90%).
- •BCRX grew revenue faster over the past five years (64.07% vs 54.55% CAGR).
Metrics side by side
Valuation
| Metric | ADMA | BCRX |
|---|---|---|
| P/E ratio | 14.54 | N/A |
| Forward P/E | 12.78 | N/A |
| P/S ratio | 4.61 | 2.17 |
| P/B ratio | 5.78 | N/A |
| EV / EBITDA | 10.74 | N/A |
| FCF yield | 4.94% | 17.51% |
Profitability
| Metric | ADMA | BCRX |
|---|---|---|
| Gross margin | 64.71% | 97.82% |
| Operating margin | 42.26% | 38.98% |
| Net margin | 32.98% | -40.90% |
| ROE | 41.39% | N/A |
| ROIC | 27.60% | -89.73% |
Growth (annualized)
| Metric | ADMA | BCRX |
|---|---|---|
| Revenue CAGR (5Y) | 54.55% | 64.07% |
| Total return CAGR (5Y) | 54.74% | -10.02% |
Frequently asked
- Which has grown faster, ADMA or BCRX?
- Over the past five years, BCRX grew revenue faster — ADMA at a 54.55% CAGR versus BCRX at 64.07%.
- Is ADMA or BCRX more profitable?
- ADMA runs the higher net margin — ADMA at 32.98% versus BCRX at -40.90%.
- How have ADMA and BCRX total returns compared?
- Over the past 10 years, ADMA delivered 3.85% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ADMA Biologics P/E ratioADMA Biologics ROEBioCryst Pharmaceuticals ROEADMA Biologics operating marginBioCryst Pharmaceuticals operating marginADMA Biologics revenue growthBioCryst Pharmaceuticals revenue growthADMA Biologics free cash flowBioCryst Pharmaceuticals free cash flow
ADMA Biologics & BioCryst Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.